How many insider declarations does 共同药业 have?

共同药业 has filed 2 insider declarations with AMF.

Who is the top reporting insider at 共同药业?

The top reporting insider at 共同药业 is 李明磊, based on the count of public filings.

What is the net insider buy vs sell volume on 共同药业?

Across the available history, declared buys total 0 and disposals 0.

InsidersTradesSigma

← Companies ★ Sign in to follow

共

共同药业: insider trades · France · AMF

SZSE:300966FR·AMFMcap 2.3Bn€

AMF ↗

Discover the full directors' dealings record of 共同药业, a publicly traded company based in France. Shares are listed on FR FR, under the authority of AMF. Market capitalisation: €2.3bn. The latest transaction was filed on 17 May 2024 — Sale. Among the most active insiders: 李明磊. The full history is free.

2

Insider Decl.

0

Thresholds

·

0 ops.

Buy Volume

·

2 ops.

Sell Volume

Financial data

FY ended December 2025 · cache

26.95 €

Income statement

Revenue606.2 M€

Gross profit83.5 M€14% margin

Net income−73.4 M€-12.1% margin

Balance sheet & cash

Market cap2.27 Bn€

Total debt1.30 Bn€

Free Cash Flow−125.3 M€

Last declaration on 17 May 2024

All Executives2 Thresholds Prospectus Other

Declarations0 total

No declarations found

0 of 0 declarations